Technical Analysis for PSNL - Personalis, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 50 DMA | Bearish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
BB Squeeze + Lower Band Touch | Range Contraction | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Fell Below 20 DMA | Bearish | -6.94% | |
Fell Below 200 DMA | Bearish | -6.94% | |
50 DMA Support | Bullish | -6.94% | |
Bollinger Band Squeeze | Range Contraction | -6.94% | |
BB Squeeze Started | Range Contraction | -6.94% | |
Inside Day | Range Contraction | -6.94% |
Alert | Time |
---|---|
Fell Below Lower Bollinger Band | 4 days ago |
Down 5% | 4 days ago |
Fell Below Previous Day's Low | 4 days ago |
60 Minute Opening Range Breakdown | 4 days ago |
Down 3% | 4 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/08/2024
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves approximately 45 biopharmaceutical customers, including a range of pharmaceutical companies. The company was founded in 2011 and is headquartered in Menlo Park, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmaceutical Biology Telehealth Telemedicine Genomics Medical Genetics Molecular Diagnostics Applied Genetics Cancer Therapies Analysis Services Biopsy Data Analysis Services Cancer Therapy Oncogenomics Treating Cancer
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmaceutical Biology Telehealth Telemedicine Genomics Medical Genetics Molecular Diagnostics Applied Genetics Cancer Therapies Analysis Services Biopsy Data Analysis Services Cancer Therapy Oncogenomics Treating Cancer
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.59 |
52 Week Low | 0.8912 |
Average Volume | 243,084 |
200-Day Moving Average | 1.44 |
50-Day Moving Average | 1.43 |
20-Day Moving Average | 1.50 |
10-Day Moving Average | 1.45 |
Average True Range | 0.14 |
RSI (14) | 42.53 |
ADX | 27.61 |
+DI | 25.78 |
-DI | 15.19 |
Chandelier Exit (Long, 3 ATRs) | 1.42 |
Chandelier Exit (Short, 3 ATRs) | 1.61 |
Upper Bollinger Bands | 1.67 |
Lower Bollinger Band | 1.33 |
Percent B (%b) | 0.03 |
BandWidth | 22.70 |
MACD Line | 0.00 |
MACD Signal Line | 0.02 |
MACD Histogram | -0.0158 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.49 | ||||
Resistance 3 (R3) | 1.50 | 1.46 | 1.47 | ||
Resistance 2 (R2) | 1.46 | 1.42 | 1.46 | 1.46 | |
Resistance 1 (R1) | 1.40 | 1.40 | 1.38 | 1.39 | 1.45 |
Pivot Point | 1.36 | 1.36 | 1.35 | 1.36 | 1.36 |
Support 1 (S1) | 1.30 | 1.32 | 1.28 | 1.29 | 1.23 |
Support 2 (S2) | 1.26 | 1.30 | 1.26 | 1.22 | |
Support 3 (S3) | 1.20 | 1.26 | 1.22 | ||
Support 4 (S4) | 1.19 |